Compounds > 1,10-phenanthroline
Page last updated: 2024-10-21

1,10-phenanthroline and Head and Neck Neoplasms

1,10-phenanthroline has been researched along with Head and Neck Neoplasms in 1 studies

1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases

Head and Neck Neoplasms: Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, D1
Peng, S1
Amin, AR1
Rahman, MA1
Nannapaneni, S1
Liu, Y1
Shin, DM1
Saba, NF1
Eichler, JF1
Chen, ZG1

Other Studies

1 other study available for 1,10-phenanthroline and Head and Neck Neoplasms

ArticleYear
Antitumor Activity of 2,9-Di-Sec-Butyl-1,10-Phenanthroline.
    PloS one, 2016, Volume: 11, Issue:12

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cisplatin; Drug

2016